Investor Presentation · 2025
American Peptides
Building the next-generation, all-American-made peptide company — from clinical-grade therapeutics to consumer packaged goods. We're capitalizing on a generational opportunity at the intersection of biosciences and mass-market distribution.
Market Opportunity
The Peptide Revolution Is Just Beginning
The global peptide therapeutics market is projected to exceed $100 billion by 2028, growing at a CAGR of 11%. Yet we remain in the first inning. Consumer awareness is accelerating — driven by viral adoption of GLP-1 agonists — while the broader peptide category remains vastly under-commercialized. The convergence of regulatory tailwinds, manufacturing innovation, and consumer demand creates a once-in-a-generation window for a vertically integrated peptide brand to own the category.
$100B+
Market by 2028
Peptide therapeutics TAM
11%
Annual CAGR
Sustained double-digit trajectory
1st
Inning
Consumer adoption still early
The Brand
American Peptides — The Brand Platform
We've secured the premium domain and intellectual property around American Peptides, establishing a brand identity that signals trust, quality, and domestic manufacturing excellence. Our positioning is intentional: in a market flooded with unregulated overseas compounds, we are building the gold standard for U.S.-made peptide products.
Premium Domain Secured
AmericanPeptides.com and associated IP fully acquired
U.S. Manufacturing Partner
Partnering with a domestic cGMP facility for end-to-end production
Quality & Compliance
Built for FDA-aligned standards from day one
Strategic Partnerships
High-Profile Partnerships in Motion
We are pursuing marquee partnerships that instantly validate the brand and unlock massive distribution channels. These early conversations position American Peptides at the nexus of beauty, defense, and enterprise wellness.
Miss USA Partnership
In early-stage talks to become the official peptide line for Miss USA — aligning our brand with beauty, wellness, and national visibility on a global stage.
Department of Defense
Exploring supply agreements with the DOD for performance and recovery peptides, addressing warfighter readiness and resilience programs.
Fortune 500 Enterprise
Engaging Fortune 500 companies to integrate peptide supplementation into corporate wellness benefits and employee health platforms.
Market Presence
Expo West 2026 — Launching on the World Stage
We're exhibiting at Natural Products Expo West — the world's largest CPG tradeshow — taking place March 3-6, 2026 at the Anaheim Convention Center. This is where the industry's biggest deals happen, and we'll be positioned to secure distribution partnerships, retail buyers, and strategic investors.
March 3-6, 2026
Four days of high-impact meetings with buyers and partners
Anaheim Convention Center
The epicenter of natural products and functional foods
BD & Distribution Focus
Targeting retail chains, distributors, and co-manufacturing partners
Distribution Strategy
Telehealth-Powered Nationwide Access
Direct-to-Consumer Telehealth
We're building a proprietary telehealth platform to prescribe, consult, and deliver peptide products to consumers across all 50 states. This vertically integrated model combines clinical oversight with frictionless e-commerce — enabling personalized peptide protocols at scale.
Why this matters: Telehealth removes the gatekeepers. Patients get expert guidance while we capture the full margin stack from consultation to fulfillment.
1
Licensed Providers
Board-certified clinicians reviewing every patient protocol
2
Personalized Protocols
Custom peptide regimens based on individual health profiles
3
Nationwide Shipping
Cold-chain fulfillment delivering to every U.S. zip code
4
Recurring Revenue
Subscription model with high retention and predictable LTV
CPG Innovation
Launching the First Peptide Beverage Line
In partnership with Adaptophoria, we are developing the world's first peptide-infused soft drink line — bringing bioactive peptides to the $400B+ global beverage market. This isn't another functional drink. It's a category creation moment.
Peptide Soft Drinks
Ready-to-drink formulations targeting energy, recovery, and cognitive performance in a familiar, enjoyable format.
Adaptophoria Partnership
Leveraging proven adaptogenic formulation expertise to create shelf-stable, bioavailable peptide beverages.
Mass Retail Distribution
Targeting convenience stores, grocery chains, and health retailers — meeting consumers where they already shop.
Product Pipeline
Beyond Beverages — The Full CPG Arsenal
We envision peptides everywhere consumers already reach for health and wellness products. Our pipeline extends across novel delivery mechanisms designed for convenience, bioavailability, and mass-market appeal. Each format uses liposomal delivery technology to maximize absorption.
🧴 Peptide Patches
Transdermal delivery for sustained-release peptide absorption throughout the day
💧 Peptide Strips
Dissolvable oral strips for rapid sublingual absorption — discreet and fast-acting
🫧 Peptide Gum
Functional chewing gum delivering peptides via buccal mucosa for convenient daily dosing
🎯 Peptide Pouches
Nicotine-pouch-style format adapted for peptide delivery — familiar form, revolutionary function
We believe the products found in every convenience store and pharmacy — from energy shots to cold remedies — will ultimately be peptide-powered. We intend to lead that transformation.
Category Disruption
Peptides Will Reshape Every Wellness Category
Peptides aren't a niche — they're a platform technology that will infuse and evolve nearly every health and wellness product on the market. Our product strategy targets the highest-value verticals where peptides deliver clinically meaningful outcomes.
Vitamin C & Immunity
$15B+ market. Replace Emergen-C, Airborne, immune gummies with peptide-powered immune defense.
ED & Sexual Wellness
$7B+ market. Disrupt Viagra, Cialis with peptide formulations for performance and libido enhancement.
Energy & Focus
$86B+ market. Replace Red Bull, 5-Hour Energy, Celsius with peptide-infused cognitive and physical energy.
Muscle & Performance
$18B+ market. Evolve protein powders, creatine, pre-workouts with bioactive muscle-building peptides.
Weight Loss & Metabolism
$280B+ market. GLP-1 peptides are already reshaping obesity treatment — we're bringing it to CPG.
Skincare & Anti-Aging
$145B+ market. Collagen peptides, skin repair, and longevity formulations in topicals and ingestibles.
Nootropics & Cognition
$10B+ market. Replace racetams and caffeine with peptide-based brain optimization.
Sleep & Recovery
$78B+ market. Disrupt melatonin, ZzzQuil, sleep aids with peptide-driven deep sleep and recovery.
Joint Health & Mobility
$9B+ market. Replace glucosamine with peptides for cartilage repair and inflammation reduction.
Gut Health & Digestion
$49B+ market. Probiotics meet peptides for gut lining repair and microbiome optimization.
Combined TAM: $700B+ across categories. American Peptides isn't targeting one vertical — we're building the platform that transforms them all.

Our Format Strategy

🥤 Beverages Peptide soft drinks, energy drinks, functional waters — mass retail distribution 🫧 Oral Formats Gum, strips, pouches, lozenges — convenient daily dosing 💊 Capsules & Tablets Premium supplement line for targeted therapeutic protocols 🧴 Topicals & Patches Transdermal delivery for skincare, pain relief, and sustained release Every format. Every category. One trusted American brand.

R&D Foundation
Funding Novel Peptide Research
Science-First Approach
We're not just a brand — we're investing in the foundational science that will define the next generation of peptide products. Our R&D initiatives focus on breakthrough delivery mechanisms that unlock new form factors and improve bioavailability.
01
Novel Delivery Mechanisms
Liposomal encapsulation, transdermal systems, and oral bioavailability enhancement
02
Formulation Optimization
Stability testing for shelf-stable CPG applications across temperature ranges
03
Clinical Validation
Pursuing evidence-based claims to differentiate from the unregulated gray market
Investment Opportunity
The Opportunity Is Now
American Peptides sits at the convergence of explosive market growth, consumer demand, and a wide-open competitive landscape. We have the domain expertise in biosciences, the go-to-market playbook, and the early partnerships to define and dominate the peptide CPG category.
🏭 Domestic Manufacturing
U.S.-made quality in a market plagued by overseas uncertainty
🤝 Marquee Partners
Miss USA, DOD, and Fortune 500 conversations underway
📈 Category Creation
First-mover in peptide beverages, gum, patches, and strips
🔬 R&D Moat
Funding novel research to sustain long-term competitive advantage
We're not entering the peptide market. We're building the brand that defines it.
Leadership
World-Class Leadership
American Peptides is led by proven operators with deep expertise in building billion-dollar brands, navigating complex regulatory environments, and scaling consumer health companies from concept to category dominance.
Cameron Forni — Chief Executive Officer
Cameron brings deep expertise in building billion-dollar businesses across medicinal and consumer goods verticals through his experience leading Select, Cura Cannabis Solutions (NAS: CURLF) and Adaptaphoria.
He has led management and overall operational execution for category-defining brands, establishing industry standards and developing partnerships across verticals.
Billion-Dollar Brand Builder
Proven track record scaling health and wellness companies to unicorn valuations
$100M+ Capital Raised
Successfully raised hundreds of millions across multiple funding rounds and partnerships
Strategic Partnership Expert
Built diverse partnership ecosystems across retail, institutional, and government verticals
Greg Gopman — Chief Operating Officer
Greg is a tech entrepreneur with over 20 years building technology and event companies. His Operational succes technology innovation, and strategic growth initiatives. His expertise spans blockchain infrastructure, cloud computing, marketing, and scaling startups from concept to market leadership.
Serial Tech Entrepreneur
Founded Akash Network (decentralized cloud), Mewn Media (Web3 marketing consultancy), and AngelHack (startup events)
Tech, Longevity & Peptide Expert
Built distributed computing platforms and consulted for blockchain companies before transitioning into Longevity and building PeptideDAO.
Growth & Marketing Strategist
15+ years helping startups scale through community building, go-to-market strategies, and strategic partnerships